A Pilot Study of Lenalidomide Alternating With Ipilimumab Post Allogeneic and Autologous Stem Cell Transplantation
Phase of Trial: Phase 0
Latest Information Update: 27 Apr 2017
At a glance
- Drugs Ipilimumab (Primary) ; Lenalidomide (Primary)
- Indications B cell lymphoma; Diffuse large B cell lymphoma; Haematological malignancies; Mantle-cell lymphoma
- Focus Adverse reactions
- 06 Dec 2016 Preliminary results (n=16) presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.
- 05 Nov 2014 Last checked against M.D. Anderson.
- 01 Nov 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.